350 руб
Журнал «Технологии живых систем» №4 за 2011 г.
Статья в номере:
ДИАГНОСТИЧЕСКОЕ И ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ P16INK4A У БОЛЬНЫХ С ЦЕРВИКАЛЬНЫМИ ИНТРАЭПИТЕЛИАЛЬНЫМИ НЕОПЛАЗИЯМИ И МИКРОКАРЦИНОМОЙ ШЕЙКИ МАТКИ
Ключевые слова: CIN рак шейки матки ВПЧ-инфекция p16INK4a прогноз
Авторы:
Любовь Ивановна Короленкова - к.м.н, ст. науч. сотрудник, Поликлиника РОНЦ им. Н.Н. Блохина РАМН (Москва).
Аннотация:
Представлен обзор работ, посвященных диагностическому и прогностическому значению p16INK4a у больных с персистирующей ВПЧ-ин¬фекцией, CIN и ранними формами рака шейки матки. Проведенный анализ литературы позволил определить области наиболее значимого практического применения данного маркера: сортировка женщин с аномальными мазками на группы с продуктивной и трансформирующей ВПЧ-инфекцией и ведение пациенток с сохранившейся после органосохраняющего лечения тяжелых CIN вирусной нагрузкой.
Страницы: 38-43
Список источников
  1. Роговская С.И. Папилломовирусная инфекция у женщин и патология шейки матки. М.: ГЭОТАР-Медиа. 2008.
  2. Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide // J. Pathol. 1999. V. 189(1). P.12 - 9.
  3. www.who.int/hpvcentre
  4. Petry K.U. Textbook of Gynecological Oncology. Güneş Publishing. 2009. P. 63 - 66.
  5. Naucler P., Ryd W., Törnberg S. et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening // J. Natl. Cancer. Inst. 2009. V. 101(2). P. 88 - 99.
  6. Ullal A., Roberts M, Bulmer J.N. et al.The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia // Cytopathology. 2008. V. 20(6). P.359 - 366.
  7. Nassar A., O'Reilly K., Cohen C., Siddiqui M.T. Comparison of p16(INK4A) and Hybrid Capture(R) 2 human papillomavirus testing as adjunctive tests in liquid - based gynecologic SurePathtrade mark preparations // Diagn. Cytopathol. 2008. V. 36(3). P. 142 - 148.
  8. БаггишМ. Кольпоскопия.М.:Практика. 2008.
  9. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P.et al. Type dependent integration frequency of human papillomavirus genomes in cervical lesions // Cancer. Res. 2008. V. 68. P. 307 - 13.
  10. Clarke B., Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix // Gynecol. Oncol. 2001. V. 82(2). P. 238 - 46.
  11. Masumoto N., Fujii T., Ishikawa M.et al. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix // Hum. Pathol. 2003. V. 34(8). P. 778 - 83.
  12. Tota J., Franco E.L. HPV infection and cervical cancerogenesis: epidemiology and prevention // Textbook of Gynecological Oncology // Güneş Publishing. 2009. P. 49 - 52.
  13. Wentzensen N., von Knebel D.M.Biomarkers in cervical cancer screening // Dis. Markers. 2007. V. 23. P. 15 - 30.
  14. Gonzalez S.L., Stremlau M., He X. et al. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7 // J. Virol. 2001. V. 75. P. 7583 - 91.
  15. Lambert A.P., Anschau F., and Schmitt V.M. p16INK4A expression in cervical premalignant and malignant lesions // Exp. Mol. Pathol. 2006. V. 80. P. 192 - 6.
  16. Queiroz C., Silva T.C., Alves V.A., Villa L.L., Costa M.C. Travassos AG et al. P16(INK4a) expression as a potential prognostic marker in cervical pre - neoplastic and neoplastic lesions // Pathol. Res. Pract. 2006. V. 202. P. 77 - 83.
  17. Ishikawa M., Fujii T., Saito M. et al. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia // Int. J. Gynecol. Cancer. 2006 Jan - Feb. V. 16(1). P. 347 - 53.
  18. Benevolo M., Mottolese M., Marandino F. et al. Immunohistochemical expression of p16(INK4a) is predictive of HR - HPV infection in cervical low - grade lesions // Mod. Pathol. 2006 Mar. V. 19(3). P. 384 - 91.
  19. Ikeda K., Tate G., Suzuki T., Mitsuya T. Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: An immunohistochemical analysis and review of the literature // Gynecol. Oncol. 2008 Jan 11.
  20. Tsoumpou I., Arbyn M., Kyrgiou M. et al. p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta - analysis // Cancer. Treatment. Reviews. 2009. V. 35 (3). P. 210 - 220.
  21. Lesnikova I., Lidang M., Hamilton - Dutoid S., Koch J. p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 arc­hival specimens // Diagn. Pathol. 2009. Jul. 9. V.4(1). H. 22.
  22. Klaes R., Friedrich T., Spitkovsky D. et al. Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri // Int. J. Cancer. 2001. V. 92. P. 276-284.
  23. Dray M., Russell P., Dalrymple C. et al.p16(INK4a) as a complementary marker of high - grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies // Pathology. 2005 Apr. V. 37(2). P. 112 - 24.
  24. Hu L., Guo M., He Z. et al. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. // Mod. Pathol. 2005 Feb. V. 18(2). P. 267 - 73.
  25. Rocha A.S., Bozzetti M.C., Kirschnick L.S., Edelweiss M.I.Antibody anti - p16(INK4a) in cervical cytology // Acta. Cytol. 2009 May - Jun. V. 53(3). P. 253 - 62.
  26. Pientong C., Ekalaksananan T., Kongyingyoes B. et al.Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection //Diagn. Cytopathol. 2004. V. 31. P. 235-242.
  27. Agoff S.N., Lin P., Morihara J., et al. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki - 67 expression and detection of high - risk HPV types. // Mod. Pathol. 2003 Jul;16(7):665 - 73.
  28. Branca M., Ciotti M., Santini D. et al.p16(INK4A) expression is related to grade of cin and high - risk human papillomavirus but does not predict virus clearance after conization or disease outcome // Int. J. Gynecol. Pathol. 2004 Oct. V. 23(4). P. 354 - 65.
  29. Branca M., Giorgi C., Santini D.et al.Aberrant expression of VEGF - C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer // J. Clin. Pathol. 2006. V. 59(1). P. 40 - 7.
  30. Branca M., Ciotti M., Giorgi C. et al. Predicting High - Risk Human Papillomavirus Infection, Progression of Cervical Intraepithelial Neoplasia, and Prognosis of Cervical Cancer With a Panel of 13 Biomarkers Tested in Multivariate Modeling // Int. J. Gynecol. Pathol. 2008 Feb 27.